This information was published on 2019-04-12T08:43:33 for IP Right Registration Published.
| Field | Value |
| (210) | 1950633 (IR 1419299) |
| (220) |
25 Jun 2018
|
| (300) |
BX, 06 Feb 2018, 1369304
|
| (511) (510) |
Class 5
Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals and biological materials both as spatially defined arrays and solutions or reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring or predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, pharmaceutical preparations; pharmaceutical eye drops Class 42 Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical and biopharmaceutical research and development; (bio)pharmaceutical product evaluation; research into treatment of cardio vascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals |
| (540) | OXURION |
| (550) | Word |
| (730) |
ThromboGenics
|
Find out more about publications on the About page.